Ming-Yow Hung | Interventional Cardiology | Best Researcher Award

Posted on 17/02/202517/02/2025 by Pencis

Prof. Ming-Yow Hung | Interventional Cardiology | Best Researcher Award

Prof. Ming-Yow Hung, Shuang Ho Hospital, Taipei Medical University, Taiwan

Professor Ming-Yow Hung is a distinguished cardiologist and academic based at Shuang Ho Hospital, Taipei Medical University, in Taipei, Taiwan. He earned his Doctor of Medicine degree from Chang Gung University in 1996, followed by a Master of Science and a Ph.D. in Clinical Medical Sciences from the same institution in 2007 and 2017, respectively. Since 2022, he has been serving as a Professor in the Department of Internal Medicine at Taipei Medical University. His clinical expertise encompasses coronary interventions, peripheral interventions, and echocardiography. Professor Hung has received several accolades, including the 2022 TMU Academic Research Award and recognition in “Who’s Who in Medicine and Healthcare” in 2011 and 2012. His research interests focus on the mechanisms of inflammatory cytokines in coronary spasm and the anatomical and functional changes in the left ventricle of patients with coronary spasm.

Author Profile

Scopus Profile

Orcid Profile

🎓 Education:

Professor Ming-Yow Hung completed his medical education at the School of Medicine, College of Medicine, Chang Gung University, in Taoyuan, Taiwan, where he studied from September 1989 to June 1995. After earning his medical degree, he undertook an internship at Chang Gung Memorial Hospital in Taoyuan from June 1995 to June 1996. He later pursued postgraduate education, obtaining a Ph.D. in Clinical Medical Sciences from the Graduate Institute of Clinical Medical Sciences at Chang Gung University College of Medicine, where he studied from September 2007 to August 2017, further advancing his expertise in the field.

🏥Work Experience:

Professor Ming-Yow Hung began his military service as a Lieutenant General Physician in the Navy of Taiwan from August 1996 to May 1998. Afterward, he completed his residency in Internal Medicine at Chang Gung Memorial Hospital, Taoyuan, Taiwan, from July 1998 to June 2001, followed by a two-year cardiology fellowship from July 2001 to June 2003. He served as an attending cardiologist at the same hospital from July 2003 to May 2008. Since 2008, Professor Hung has been an attending cardiologist at Shuang Ho Hospital, Taipei Medical University. In academia, he progressed from Assistant Professor (2011-2017) to Associate Professor (2017-2022) and has been a Full Professor since February 2022.

🌟Professional Activities:

Professor Ming-Yow Hung has been actively involved in various professional roles throughout his career. From September 2004 to August 2005, he served on the Medical Record Management Committee at Chang Gung Memorial Hospital, Taoyuan. He was part of the Committee of Clinical Techniques and Medical Care for Clerkship Training from 2005 to 2006. He also served as the Director of the Intensive Care Unit at Shuang Ho Hospital from 2008 to 2009. Professor Hung was a faculty member at the 8th Annual Complex Cardiovascular Catheter Therapeutics Global Summit in 2012. He was the Director of Interventional Cardiology and Cardiac Cath Lab from 2014 to 2018. Additionally, he contributed to the Academic Educational Committee of the Taiwan Society of Echocardiography from 2008 to 2010.

🔬Research Interest:

Professor Ming-Yow Hung’s research interests focus on several key areas within cardiology. He specializes in interventional cardiology, particularly exploring innovative techniques and approaches in coronary and peripheral interventions. Additionally, his work emphasizes echocardiography, where he investigates advanced imaging techniques to enhance diagnostic accuracy and patient outcomes. Professor Hung is also deeply engaged in basic cardiovascular science, conducting research to better understand the underlying mechanisms of cardiovascular diseases. Through these areas of research, he aims to contribute to the advancement of both clinical practices and scientific knowledge in the field of cardiology.

🏆Honors and Awards:

Professor Ming-Yow Hung has received numerous honors and awards throughout his career. In 2001, he earned the Second Best Chart Record Award from the Department of Internal Medicine at Chang Gung Memorial Hospital. He was included in the 28th edition of Who’s Who in the World and the Who’s Who in Medicine and Healthcare (2011-2012). Notable accolades include invitations to speak at prestigious events like the Cardiology Grand Round at the University of California, San Diego, and the Complex Cardiovascular Catheter Therapeutics Global Summit. He also received multiple research awards from Taipei Medical University in 2014 and 2015, as well as recognition for his research achievements at Shuang Ho Hospital and various conferences in 2019 and 2022.

🌍Conclusion:

Professor Ming-Yow Hung is a highly accomplished cardiologist and academic, with expertise in interventional cardiology, echocardiography, and basic cardiovascular science. His extensive education, military service, and career at top medical institutions like Chang Gung Memorial Hospital and Taipei Medical University showcase his dedication to both clinical practice and research. Throughout his career, he has been recognized with numerous awards for his contributions to medicine and healthcare. His work continues to impact the field of cardiology, improving patient care and advancing scientific understanding.

Top Notable Publications

From Acute Carditis, Rheumatic Carditis, and Morphologic Cardiac Reactions to Allergic Angina, Allergic Myocardial Infarction and Kounis Syndrome: A Multidisciplinary and Multisystem Disease

Journal: Preprint

Year: 2025

Effects of statins in patients with coronary artery spasm: A nationwide population‐based study

Journal: Clinical and Translational Science

Cardio-Oncoimmunology: Cardiac Toxicity, Cardiovascular Hypersensitivity, and Kounis Syndrome

Journal: Life

Cardio-Oncology: Cardiac Toxicity, Cardiovascular Hypersensitivity, and Kounis Syndrome

Journal: Preprint

“When”, “Where”, and “How” of SARS-CoV-2 Infection Affects the Human Cardiovascular System: A Narrative Review

Journal: Preprint

Outcomes of Atrioventricular Node Ablation and Pacing in Patients with Heart Failure and Atrial Fibrillation: From Cardiac Resynchronization Therapy to His Bundle Pacing

Journal: Journal of Cardiovascular Development and Disease

Year: 2023

Coronary Artery Spasm-Related Heart Failure Syndrome: Literature Review

Journal: International Journal of Molecular Sciences

Year: 2023

Relationship between Inflammation and Vasospastic Angina

Journal: Medicina

Year: 2023

The Effect of Long COVID-19 Infection and Vaccination on Male Fertility; A Narrative Review

Journal: Vaccines

Year: 2022

Apolipoprotein (a)/Lipoprotein(a)-Induced Oxidative-Inflammatory α7-nAChR/p38 MAPK/IL-6/RhoA-GTP Signaling Axis and M1 Macrophage Polarization Modulate Inflammation-Associated Development of Coronary Artery Spasm

Journal: Oxidative Medicine and Cellular Longevity

Year: 2022

Atsuko Nakayama | Cardiac Rehabilitation | Best Researcher Award

Posted on 17/02/202517/02/2025 by Pencis

Dr. Atsuko Nakayama | Cardiac Rehabilitation | Best Researcher Award

Dr. Atsuko Nakayama, Sakakibara Heart Institute, Japan

Dr. Atsuko Nakayama, M.D., Ph.D., is a renowned cardiologist and expert in cardiovascular medicine and rehabilitation at the Sakakibara Memorial Hospital in Japan. She serves as the Director of the Department of Cardiovascular Medicine, Head of the Cardiac Rehabilitation Unit, and Director of the Comprehensive Support Center for Heart Disease. Dr. Nakayama is a pioneer in integrating AI and telemedicine into cardiac care and rehabilitation, with a focus on personalized treatment plans and wearable technologies. She holds leadership roles in several professional organizations and contributes to national policies on cardiovascular disease as a member of Japan’s Ministry of Health, Labour, and Welfare.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

🎓EARLY ACADEMIC PURSUITS:

Dr. Atsuko Nakayama’s academic journey began with a strong foundation in medicine, culminating in a Doctorate from the prestigious University of Tokyo in March 2012. Her passion for cardiovascular medicine was evident from early on, and her academic excellence set the stage for a career that would merge clinical practice with cutting-edge research. Her early studies laid the groundwork for her future focus on medical device development, telemedicine, and rehabilitation in the cardiovascular field.

🏥PROFESSIONAL ENDEAVORS:

Dr. Nakayama currently holds multiple leadership roles at the Sakakibara Memorial Hospital, where she serves as the Director of the Department of Cardiovascular Medicine, Head of the Cardiac Rehabilitation Unit, and Director of the Comprehensive Support Center for Heart Disease. Her leadership extends beyond her hospital, as she has been appointed as the representative of the Heart Disease Work-Life Balance Support Network in December 2024. Additionally, since June 2024, Dr. Nakayama has been a member of the Cardiovascular Disease Control Promotion Council under Japan’s Ministry of Health, Labour, and Welfare.

Her professional endeavors reflect a commitment to both the clinical and policy aspects of cardiovascular health. She has been at the forefront of integrating new technologies and rehabilitation approaches into routine care, improving patient outcomes through innovation.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIAC REHABILITATION:

Dr. Nakayama’s research has focused on advancing the integration of technology in cardiovascular medicine, particularly through the use of artificial intelligence (AI) and telemedicine. She is recognized for her work in developing AI-driven diagnostic tools, wearable technologies, and remote cardiac rehabilitation programs. Her research also spans exercise physiology, aortic aneurysms, hypertrophic cardiomyopathy, and healthcare quality assessment.

Her pioneering work has enabled the development of AI-assisted patient monitoring systems and personalized treatment plans, revolutionizing cardiac rehabilitation. Dr. Nakayama has been instrumental in incorporating AI and big data analytics into cardiovascular care, allowing for predictive and preventive interventions in heart disease.

🌍IMPACT AND INFLUENCE:

Dr. Nakayama’s contributions extend well beyond the hospital and laboratory. Through her leadership in various professional organizations, including serving as the chair of the JCS-JJC committee of the Japanese Circulation Society since 2022, she has influenced the direction of cardiovascular research and practice in Japan. Her role in national policy-making, including her position on the Cardiovascular Disease Control Promotion Council, allows her to shape public health initiatives and promote AI-powered healthcare solutions on a national scale.

Her influence has been recognized by prestigious awards, including the “STI for SDGs” Award from the Japan Science and Technology Agency in 2024, recognizing her groundbreaking work in remotecardiac rehabilitation

📚ACADEMIC CITATIONS:

Dr. Nakayama’s research has been widely cited in the fields of telemedicine, AI in healthcare, and cardiovascular rehabilitation. Her work has paved the way for numerous studies exploring the use of technology to improve patient outcomes. As a fellow of both the Japanese Circulation Society and the American Heart Association, her research continues to have a significant impact on the scientific community.

🔮LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Nakayama’s legacy is one of innovation, leadership, and compassionate care. Her contributions to AI-driven healthcare, particularly in the field of cardiology, have set new standards in patient care and rehabilitation. As she continues her work in AI-assisted diagnostics and rehabilitation, her future contributions promise to further revolutionize cardiovascular medicine and improve the lives of millions of patients.

Her ongoing efforts to shape policies, integrate cutting-edge technologies into clinical practice, and advocate for better healthcare systems ensure that Dr. Nakayama’s impact will be felt for years to come, leaving a lasting legacy in the world of medicine.

🌟CONCLUSION:

Dr. Atsuko Nakayama is a trailblazer in the field of cardiovascular medicine, combining clinical expertise with groundbreaking research in AI and telemedicine. Her leadership at Sakakibara Memorial Hospital, coupled with her contributions to national health policies, has made a lasting impact on cardiac care and rehabilitation in Japan. Through her innovative use of technology, she continues to improve patient outcomes and shape the future of healthcare. Dr. Nakayama’s dedication to advancing both medicine and healthcare systems ensures that her work will inspire generations of clinicians and researchers.

TOP NOTABLE PUBLICATIONS:

A national survey of career development according to gender and subspecialties among cardiologists in Japan
Authors: M. Shimbo, A. Nakayama, N. Fukue, T. Taniguchi, Y. Kobayashi
Journal: PLoS ONE
Year: 2025

Predicting Heart Rate at the Anaerobic Threshold Using a Machine Learning Model Based on a Large-Scale Population Dataset
Authors: A. Nakayama, T. Iwata, H. Sakuma, K. Kashino, H. Tomoike
Journal: Journal of Clinical Medicine
Year: 2025

Impact of Long-Term Exercise-Based Cardiac Rehabilitation in Patients With Chronic Heart Failure ― A Systematic Review and Meta-Analysis
Authors: S. Yamamoto, M. Okamura, Y. Akashi, S. Makita, M. Isobe
Journal: Circulation Journal
Year: 2024
Citations: 2

Sex Differences in Cardiovascular Disease-Related Hospitalization and Mortality in Japan ― Analysis of Health Records From a Nationwide Claim-Based Database, the Japanese Registry of All Cardiac and Vascular Disease (JROAD)
Authors: S. Noma, K. Kato, T. Otsuka, K. Maemura, Y.T. Tsukada
Journal: Circulation Journal
Year: 2024

Litao Guo | Cardiac Rehabilitation | Best Researcher Award

Posted on 17/02/202517/02/2025 by Pencis

Prof. Litao Guo | Cardiac Rehabilitation | Best Researcher Award

Prof. Litao Guo, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China

Prof. Litao Guo is a Deputy Director and Associate Chief Physician at The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China. With over 18 years of experience in intensive care medicine, he specializes in cardiopulmonary resuscitation (CPR), ECMO therapy, and critical patient management. Prof. Guo is also an expert in intelligent simulation teaching for emergency skills training. His research includes advanced ECMO treatments and innovative CPR training methods using intelligent simulation platforms. He has published 16 research papers, contributing significantly to critical care medicine and improving patient outcomes in high-risk medical situations.

AUTHOR PROFILE

Scopus Profile

🎓EARLY ACADEMIC PURSUITS:

Prof. Litao Guo embarked on his academic journey in intensive care medicine, where he spent more than 18 years developing his expertise. From a resident to an associate chief physician, he gained valuable experience and hands-on knowledge in managing critically ill patients. Prof. Guo has also served as a master tutor, fostering the next generation of healthcare professionals, particularly in cardiopulmonary resuscitation (CPR) and ECMO treatment. This foundation in intensive care provided him with a deep understanding of patient management and critical interventions.

💼PROFESSIONAL ENDEAVORS:

Currently, Prof. Guo serves as the Deputy Director and Associate Chief Physician at The First Affiliated Hospital of Xi’an Jiaotong University in Xi’an, China. His daily responsibilities include overseeing the treatment and management of critically ill patients, particularly those requiring advanced life-saving procedures such as ECMO and CPR. He plays a pivotal role in shaping clinical practices, guiding patient care, and contributing to the advancement of intensive care medicine. His leadership is integral to the hospital’s focus on improving patient outcomes in high-stakes medical situations.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON CARDIAC REHABILITATION:

Prof. Guo is widely recognized for his research on intelligent simulation teaching and training methods, particularly in CPR. His work involves leveraging cutting-edge technology to enhance the teaching and practical skills of medical staff in emergency procedures. He has been instrumental in developing an intelligent simulation platform to train teams in effective CPR techniques, emphasizing team coordination, division of labor, and the standing position during resuscitation efforts. Additionally, his research delves into the management of ECMO therapy, focusing on treating complications such as massive airway bleeding with early clamping and advanced intervention measures.

🌍IMPACT AND INFLUENCE:

Prof. Guo’s research and clinical contributions have had a significant impact on improving outcomes for critically ill patients. His work on ECMO combined with advanced airway management has been especially groundbreaking, offering new insights and techniques to reduce mortality rates. His intelligent simulation teaching platform is transforming the way first responders and healthcare professionals are trained, ensuring they are equipped with the best skills to save lives. Prof. Guo’s publications, including 16 relevant research papers, have gained widespread recognition within the medical community.

📚ACADEMIC CITATIONS:

Prof. Guo has published 16 research papers, many of which focus on innovative approaches to CPR and ECMO. His scholarly work has contributed to the growing body of knowledge in intensive care medicine, particularly in areas that directly affect patient survival in critical care settings. These publications are frequently cited by other researchers, underscoring the importance of his work in advancing medical practice.

🔮LEGACY AND FUTURE CONTRIBUTIONS:

Prof. Guo is dedicated to further advancing intensive care medicine through both his clinical practice and research endeavors. His focus on innovative training techniques and treatment protocols, such as ECMO and CPR management, ensures that future healthcare providers will be well-equipped to manage complex and life-threatening situations. His legacy will be one of continuous improvement in the fields of sepsis, resuscitation, and critical care, with lasting effects on the healthcare system and patient care outcomes.

🌟CONCLUSION:

Prof. Litao Guo’s work in intensive care medicine, particularly in cardiopulmonary resuscitation (CPR) and ECMO therapy, has had a profound impact on improving patient care and outcomes in critical settings. His pioneering research on intelligent simulation platforms for emergency training is revolutionizing medical education, ensuring better preparedness among healthcare teams. With over 18 years of experience and 16 published papers, his contributions continue to shape the field. Prof. Guo’s commitment to advancing both clinical practice and medical education ensures that his legacy will inspire future generations of healthcare professionals.

TOP NOTABLE PUBLICATIONS

Exploration of cardiopulmonary resuscitation teamwork training for maternal cardiac arrest using the SimMan intelligent simulation platform: A simulation teaching study

Authors: Zhang, Ruirui; Liu, Yu; Zhang, Mingming; Bai, Hongliang; Guo, Litao

Journal: Health Science Reports

Year: 2024

Regional Practice Variation and Outcomes in the Standard Versus Accelerated Initiation of Renal Replacement Therapy in Acute Kidney Injury (STARRT-AKI) Trial: A Post Hoc Secondary Analysis

Authors: Vaara, Suvi T.; Neto, Ary Serpa; Bellomo, Rinaldo; Yang, Yang; Padayachee, Laven

Journal: Critical Care Explorations

Year: 2024

Yingqiang Du | Myocardial Infarction | Best Researcher Award

Posted on 12/02/202512/02/2025 by Pencis

Dr. Yingqiang Du | Myocardial Infarction | Best Researcher Award

Dr. Yingqiang Du, Department of Cardiology, The Affiliated Suzhou Hospital of Nanjing Medical University; Suzhou Municipal Hospital; Gusu School, Nanjing Medical University, China

Dr. Yingqiang Du is a renowned cardiology researcher at The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, and Gusu School, Nanjing Medical University, China. His research focuses on myocardial infarction and ischemic heart disease, exploring inflammation, fibrosis, metabolic remodeling, and novel therapeutic strategies. As the first or corresponding author of multiple high-impact publications, he has significantly contributed to cardiovascular medicine. His work bridges basic and clinical research, influencing treatment advancements and patient care. With ongoing projects funded by prestigious grants, Dr. Du continues to drive innovation in cardiology, shaping the future of cardiovascular health research.

AUTHOR PROFILE

Scopus Profile

Orcid Profile

📚 EARLY ACADEMIC PURSUITS:

Dr. Yingqiang Du began his academic journey with a strong foundation in medical sciences, focusing on cardiology and cardiovascular research. His early education provided him with a deep understanding of human physiology, pathology, and the complexities of ischemic heart disease. With a keen interest in myocardial infarction and its underlying mechanisms, he pursued specialized training and research, laying the groundwork for his future contributions to the field.

🏥 PROFESSIONAL ENDEAVORS:

Currently, Dr. Du is affiliated with The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, and Gusu School, Nanjing Medical University. As a researcher and academic professional, he has taken on significant responsibilities in both clinical and experimental cardiology. His work bridges the gap between theoretical research and practical applications, ensuring that scientific findings translate into improved patient care.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON MYOCARDIAL INFARCTION:

Dr. Du’s research primarily centers on myocardial infarction and ischemic heart disease. His studies delve into various aspects, including:

The role of inflammation and fibrosis in cardiovascular conditions.
The impact of environmental factors, such as micro(nano)plastics, on heart disease.
Novel therapeutic approaches involving bioactive compounds like resveratrol and muscone.
The involvement of metabolic remodeling and inflammasome activation in aging cells. His extensive work provides crucial insights into the prevention, diagnosis, and treatment of cardiac disorders.

🌟 IMPACT AND INFLUENCE:

Dr. Du’s research has had a profound impact on the field of cardiology. His studies have contributed to a better understanding of the molecular mechanisms of myocardial infarction and fibrosis, paving the way for new treatment modalities. His findings have influenced clinical practices and have been referenced in various medical and scientific discussions worldwide.

📖 ACADEMIC CITES:

As an established researcher, Dr. Du has authored multiple high-impact publications in reputed journals, including:

Journal of Hazardous Materials
Clinical and Translational Medicine
Experimental and Therapeutic Medicine
Bioengineered
American Journal of Translational Research These publications, where he serves as either the first or corresponding author, reflect his credibility and expertise in the field. His work has been widely cited by peers, demonstrating its relevance and significance.

🏆 LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Du’s contributions to cardiology are paving the way for future breakthroughs in cardiovascular medicine. His research findings are not only enhancing current medical knowledge but also inspiring upcoming researchers to explore novel therapeutic strategies. Moving forward, his work is expected to contribute significantly to:

The development of innovative drug treatments for myocardial infarction.
The formulation of preventive measures against ischemic heart disease.
The exploration of new molecular pathways for better cardiovascular health. His ongoing commitment to research excellence ensures that his legacy will continue to shape the future of cardiology.

🌍CONCLUSION:

Dr. Yingqiang Du is a distinguished researcher whose groundbreaking contributions to cardiology have significantly advanced the understanding of myocardial infarction and ischemic heart disease. His extensive studies on inflammation, fibrosis, and metabolic remodeling have influenced both clinical practices and future research directions. With multiple high-impact publications and ongoing projects, his work continues to shape modern cardiovascular medicine.

TOP NOTABLE PUBLICATION

Title: Exposure to polyethylene terephthalate micro(nano)plastics exacerbates inflammation and fibrosis after myocardial infarction by reprogramming the gut and lung microbiota and metabolome

Authors: X., Gu, Xin, Z., Zhang, Zhixuan, L., Zhao, Lin, … X., Wang, Xiaoyan, Y., Du, Yingqiang

Journal: Journal of Hazardous Materials

Year: 2025

sungil im | Arrhythmia | Best Researcher Award

Posted on 27/01/202527/01/2025 by Pencis

Dr. sungil im | Arrhythmia | Best Researcher Award

Dr. sungil im, kosin university, South Korea

Dr. Sungil Im is an Associate Professor of Cardiology at Kosin University Gospel Hospital, South Korea. With a distinguished career spanning over two decades, he specializes in cardiac electrophysiology, atrial myopathy, and advanced ablation techniques for arrhythmias. Dr. Im’s global expertise includes serving as an international cooperation doctor under KOICA in Kazakhstan and contributing to leading institutions like Korea University Medical Center and Samsung Medical Center. A Fellow of the American College of Cardiology (FACC) and European Society of Cardiology (FESC), his impactful research and clinical trials continue to shape advancements in cardiology worldwide.

Author Profile

Orcid Profile

Google Scholar Profile

📚 EARLY ACADEMIC PURSUITS:

Dr. Sungil Im’s journey in medicine began with a strong foundation in internal medicine and cardiology. After obtaining his Korean Medical Doctor license in 2003, he pursued a rigorous residency at Gyeong Sang National University Hospital, specializing in general internal medicine and cardiology. His academic milestones were marked by a continuous quest for excellence, which paved the way for his clinical expertise in cardiac electrophysiology.

🩺 PROFESSIONAL ENDEAVORS:

Dr. Im’s professional journey is a testament to his dedication and versatility. From 2008 to 2011, he served as an international cooperation doctor under KOICA at the Korea-Kazakhstan Friendship Hospital. This experience underscored his global commitment to advancing healthcare. Upon returning to Korea, he held key positions such as Clinical Fellow and Assistant Professor at esteemed institutions, including the Korea University Medical Center and Samsung Medical Center. Currently, he is an Associate Professor at Kosin University Gospel Hospital, where he continues to contribute significantly to cardiology education and clinical practice.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON ARRHYTHMIA:

Dr. Im’s research interests are deeply rooted in advanced cardiac electrophysiology. His groundbreaking studies focus on atrial myopathy, cryoablation techniques for atrial fibrillation, and ventricular tachycardia ablation. His investigations into arrhythmogenesis and inflammation in atrial fibrillation patients have opened new avenues for understanding cardiac diseases. Additionally, his work on the association between ventricular arrhythmias and stroke has provided critical insights into improving patient outcomes.

🌍 IMPACT AND INFLUENCE:

Dr. Im’s influence extends beyond academia and clinical practice. He is a Fellow of the American College of Cardiology (FACC) and the European Society of Cardiology (FESC), reflecting his global recognition. As a board member of various Korean cardiology societies, he plays a vital role in shaping policies and advancing the field. His participation in multicenter clinical trials has further reinforced his reputation as a pioneer in cardiology research.

📖 ACADEMIC CITES:

Dr. Im has authored and contributed to numerous peer-reviewed studies and clinical trials, particularly in the fields of hypertension, medication adherence, and electrophysiology. His scholarly work is widely cited and respected, showcasing his intellectual contributions to cardiology.

🏆 LEGACY AND FUTURE CONTRIBUTIONS:

Dr. Sungil Im’s legacy is one of relentless pursuit of excellence and innovation. His dedication to advancing cardiac care, mentoring future cardiologists, and driving groundbreaking research continues to leave a lasting impact. Looking ahead, his work promises to further enhance our understanding of complex cardiac disorders and improve global healthcare standards.

🌟 CONCLUSION:

Dr. Sungil Im exemplifies the qualities of a world-class researcher and educator. With a career marked by global service, pioneering research, and academic leadership, he stands as a beacon of inspiration in the field of cardiology. His legacy will undoubtedly influence generations to come.

TOP NOTABLE PUBLICATIONS

Pulsed field ablation of left ventricular myocardium in a swine infarct model

Authors: SI Im, S Higuchi, A Lee, C Stillson, E Buck, B Morrow, K Schneider, …

Journal: Clinical Electrophysiology

Year: 2022

Predictors of adverse outcome in patients with frequent premature ventricular complexes: the ABC-VT risk score

Authors: A Voskoboinik, A Hadjis, C Alhede, SI Im, H Park, J Moss, GM Marcus, …

Journal: Heart Rhythm

Year: 2020

Identification of markers associated with development of stroke in “Clinically Low‐Risk” atrial fibrillation patients

Authors: SY Shin, SJ Han, JS Kim, SI Im, J Shim, J Ahn, EM Lee, YM Park, JH Kim, …

Journal: Journal of the American Heart Association

Year: 2019

Effect of epicardial pulsed field ablation directly on coronary arteries

Authors: S Higuchi, SI Im, C Stillson, ED Buck, S Jerrell, CW Schneider, M Speltz, …

Journal: Clinical Electrophysiology

Year: 2022

Gap junction remodeling by chronic pressure overload is related to the increased susceptibility to atrial fibrillation in rat heart

Authors: SY Shin, WM Jo, TJ Min, BK Kim, DH Song, SH Hyeon, JE Kwon, WS Lee, …

Journal: EP Europace

Year: 2015

Usefulness of neutrophil/lymphocyte ratio in predicting early recurrence after radiofrequency catheter ablation in patients with atrial fibrillation

Authors: SI Im, SY Shin, JO Na, YH Kim, CU Choi, SH Kim, JW Kim, EJ Kim, …

Journal: International Journal of Cardiology

Year: 2013

Impact of low-dose aspirin on coronary artery spasm as assessed by intracoronary acetylcholine provocation test in Korean patients

Authors: JY Park, SW Rha, KL Poddar, S Ramasamy, KY Chen, YJ Li, BG Choi, …

Journal: Journal of Cardiology

Year: 2012

Thyrotoxicosis with coronary spasm that required coronary artery bypass surgery

Authors: SM Lee, TS Jung, JR Hahm, SI Im, SK Kim, KJ Lee, JM Lee, SI Chung

Journal: Internal Medicine

Year: 2007

Risk factor algorithm used to predict frequent premature ventricular contraction-induced cardiomyopathy

Authors: KM Park, SI Im, SJ Park, JS Kim, YK On

Journal: International Journal of Cardiology

Year: 2017

Impact of periodontitis as representative of chronic inflammation on long-term clinical outcomes in patients with atrial fibrillation

Authors: SI Im, J Heo, BJ Kim, KI Cho, HS Kim, JH Heo, JY Hwang

Journal: Open Heart

Year: 2018

Eliza Wong | Cardiac Nursing | Best Researcher Award

Posted on 22/01/202524/01/2025 by Pencis

Dr. Eliza Wong | Cardiac Nursing | Best Researcher Award

Dr. Eliza Wong, Tung Wah College, Hong Kong

Dr. Eliza Wong is an esteemed Associate Professor at Tung Wah College, Hong Kong, with extensive experience in nursing education, research, and clinical practice. She specializes in e-health interventions, acute care, and cardiovascular nursing, focusing on preventive care, gerontechnology, and lifestyle educational programs. Dr. Wong’s impactful research has garnered substantial funding, including Health and Medical Research Fund (HMRF) grants, and her work is widely published in leading international journals. A dedicated mentor and global collaborator, she actively advances nursing education and practice, shaping the next generation of healthcare professionals and contributing to improved patient outcomes worldwide.

Author Profile

Scopus Profile

Orcid Profile

Google Scholar Profile

EDUCATION:

Dr. Wong Mi Ling, Eliza, possesses an impressive academic foundation in nursing and healthcare management. She earned her PhD in Nursing from The Chinese University of Hong Kong (2003–2009), focusing on improving patient care through evidence-based research. She also holds a Master of Nursing from Deakin University, Australia (1999–2001), and a Master of Health Administration from the University of New South Wales, Australia (1995–1997), which reflect her dual expertise in clinical practice and healthcare leadership. Additionally, she completed her Bachelor of Health Science in Nursing at the University of Western Sydney, Australia (1992–1993), establishing her strong clinical foundation.

PROFESSIONAL QUALIFICATION:

Dr. Wong Mi Ling, Eliza, boasts outstanding professional qualifications in nursing and healthcare. She is a Fellow of the Hong Kong College of Education and Research at the Hong Kong Academy of Nursing (HKAN) since 2012 . A committed member of Sigma (Pi Lota at-Large Chapter) , she has been a Registered General Nurse in Hong Kong since 1982 and a Registered Midwife since 1984 . Her international credentials include being a Registered Nurse in NSW, Australia (1990–2017). Additionally, she has certifications in International Trauma Life Support (2017–2021) and Basic Life Support (2017–2019) .

PROFESSIONAL EXPERIENCE:

Dr. Wong Mi Ling, Eliza, has an extensive professional journey in nursing and education. She serves as an Associate Professor at Tung Wah College (2021–present) and previously held roles at the Polytechnic University of Hong Kong as Principal Research Fellow (2020–2021) and Assistant Professor (2017–2020) . She has also contributed as a Nurse Educator at Hong Kong Sanatorium & Hospital (2016–2017) and Assistant Professor at CUHK (2010–2016) . Her diverse experience spans roles in nursing education, consultancy, and frontline care in Hong Kong and Australia, including A&E, obstetrics, and rehabilitation units .

RESEARCH INTERESTS ON CARDIAC NURSING:

Dr. Wong Mi Ling, Eliza, research interests encompass e-health interventions for conditions like coronary heart disease and metabolic syndrome, acute care with a focus on pain and emergency nursing, and cardiovascular nursing, including preventive care, rehabilitation, and lifestyle education. Their PhD research emphasized educational interventions in acute pain management for patients with limb fractures. With extensive experience in emergency nursing, their studies explore nurse-led wound care and triage pain management. Since 2017, they have focused on gerontechnology and health literacy for older adults, securing significant grants. Their prolific contributions include 46 international publications, numerous impactful conference papers, and active roles in collaborative research and peer review.

AWARDS AND HONORS:

Dr. Wong Mi Ling, Eliza has received numerous awards and honors throughout her distinguished career. Her accolades reflect her outstanding contributions to nursing education, research, and practice. Dr. Wong has been recognized for her impactful work in cardiovascular nursing and e-health interventions, securing prestigious research grants such as the Health and Medical Research Fund (HMRF) and Knowledge Transfer Fund. She serves as a member of the International Advisory Board for International Emergency Nursing and actively contributes as a peer reviewer for esteemed journals like BMJ Open Access and the Journal of Advanced Nursing. Her dedication continues to inspire excellence in nursing.

CITATIONS:

Citations – 2074
h-index – 26
i10-index – 58

CONCLUSION:

Dr. Wong Mi Ling, Eliza has established herself as a visionary leader in nursing, blending rich clinical experience with groundbreaking research and education. Her contributions to e-health interventions, acute care, and cardiovascular nursing have significantly advanced nursing practice and patient care. Through her commitment to mentorship, she has nurtured the next generation of healthcare professionals, fostering innovation and academic excellence. With a global reputation as a scholar, advisor, and educator, Dr. Wong continues to drive progress in nursing, ensuring her work has a lasting impact on healthcare systems and communities worldwide. Her dedication remains a beacon of inspiration and excellence.

TOP NOTABLE PUBLICATIONS

Title: The associations of e-health perception and dementia knowledge with dementia public stigma in nursing students: A cross-sectional study
Authors: Su, J.J., Tsui, K.Y., Lam, S.C., Suen, L.K.P., Kwan, R.Y.C.
Journal: Nurse Education Today
Year: 2025, 146, 106532

Title: Effect of a Nurse-Led Support Program Using Mobile Application Versus Nurse Phone Advice on Patients at Risk of Coronary Artery Disease: A Randomized Controlled Trial
Authors: Wong, E.M.L., Leung, D.Y.P., Lam, S.C., Ko, S.Y., Leung, A.Y.M.
Journal: Worldviews on Evidence-Based Nursing
Year: 2025, 22(1), e12765

Title: Lifestyle intervention using a mobile application versus booklet for adults with metabolic syndrome: a multicentre randomised controlled trial (abridged secondary publication)
Authors: Leung, D.Y.P., Wong, E.M.L., Leung, A.M.Y., Cheung, A.S.P., Cheung, K.C.
Journal: Hong Kong Medical Journal
Year: 2024, 30(6), pp. 12–16

Title: Coping strategies of internally displaced persons and the host community in a region of armed conflict: A cross-sectional study
Authors: Salihu, D., Chutiyami, M., Bello, U.M., Sulaiman, S.K., Kwan, R.Y.C.
Journal: Psychiatry Research
Year: 2024, 339, 116035

Title: Effectiveness of a home-based music-paced physical activity programme on exercise-related outcomes after cardiac rehabilitation: a randomized controlled trial
Authors: Chair, S.Y., Cheng, H.Y., Lo, S.W.S., Choi, K.C., Leung, T.S.Y.
Journal: European Journal of Cardiovascular Nursing
Year: 2024, 23(5), pp. 510–520

Title: Integrated Health Education Programmes With Physical Activity Among Community-Dwelling Older Adults at Risk of Atherosclerotic Cardiovascular Disease: An Integrative Review of Experimental Studies
Authors: Lo, F., Wong, E., Lam, K., Huang, X., Ho, K.
Journal: Journal of Advanced Nursing
Year: 2024

Title: Effects of virtual reality on anxiety and pain in adult patients undergoing wound-closure procedures: A pilot randomized controlled trial
Authors: Ko, S.Y., Wong, E.M.L., Ngan, T.L., Tam, H.F., Chan, C.C.
Journal: Digital Health
Year: 2024, 10

Title: Music-paced physical activity intervention for patients with coronary heart disease: abridged secondary publication
Authors: Chair, S.Y., Sit, J.W.H., Wong, E.M.L., Yu, D.S.F., Leung, T.S.Y.
Journal: Hong Kong Medical Journal
Year: 2024, 30(1), pp. 18–22

Title: Sensitivity and specificity of conventional and new face validation in determining the incomprehensible items by older people: Empirical evidence of testing 106 quality-of-life items
Authors: Lam, S.C., Suen, L.K.P., Huang, E.Y.-Z., Cheung, D.S.K., Kwan, R.Y.C.
Journal: Aging Medicine
Year: 2023, 6(3), pp. 230–238

Title: The effect of a lifestyle intervention program using a mobile application versus the effect of a program using a booklet for adults with metabolic syndrome: A three-arm randomized controlled trial
Authors: Wong, E.M.L., Leung, D.Y.P., Wang, Q., Leung, A.Y.M., Cheung, A.S.P.
Journal: Journal of Nursing Scholarship
Year: 2023, 55(5), pp. 936–948

Sherin Mehani | Cardiac Rehabilitation | Best Researcher Award

Posted on 12/09/202412/09/2024 by Pencis

Prof. Sherin Mehani | Cardiac Rehabilitation | Best Researcher Award

Prof. Sherin Mehani, beni-suef university, Egypt

Dr. Sherin Mehani is a distinguished researcher in the field of cardiac rehabilitation with over two decades of expertise in cardiovascular health. Her groundbreaking work focuses on developing and implementing innovative rehabilitation strategies to enhance patient outcomes and quality of life. Dr. Mehani’s research has significantly advanced the understanding of cardiac recovery processes, leading to improved therapeutic protocols and patient care standards. Her dedication to clinical excellence and research has earned her the prestigious Best Researcher Award, recognizing her exceptional contributions to the field of cardiac rehabilitation.

Profile:

Scopus Profile

Orcid Profile

Education:

Dr. Sherin Mehani has a distinguished academic background in physical therapy. She earned her Bachelor of Science in Physical Therapy from Cairo University in May 1996, graduating with honors and a Very Good degree. She continued her education at Cairo University, completing her Master of Science in Physical Therapy in 2003 with an Excellent degree, ranking first in her class with a score of 89%. Her master’s thesis focused on the effects of aerobic training on symptomatic mitral valve prolapse in females. Dr. Mehani pursued further specialization with a Ph.D. in Physical Therapy from Cairo University, awarded in 2007 with an Excellent degree and a score of 94%, again ranking first. Her doctoral research examined the role of aerobic training in patients with symptomatic idiopathic dilated cardiomyopathy. She achieved her Assistant Professor degree in Physical Therapy in 2012, with a Very Good rating of 99 points, and was promoted to Professor in 2018, with an exceptional rating of 99.3 points.

Professional Experience:

Dr. Sherin Mehani has enjoyed a distinguished career in physical therapy, marked by both academic excellence and administrative leadership. She began her professional journey as an Administrator at the Faculty of Physical Therapy, Cairo University, from 1997 to May 2003, focusing on cardiovascular-respiratory disorders and geriatrics. She then progressed to Assistant Lecturer from May 2003 to October 2007, and subsequently served as a Lecturer in cardiac rehabilitation from November 2007 to November 2012. In 2012, she was promoted to Assistant Professor at Cairo University, where she remained until 2015.

In August 2015, Dr. Mehani transitioned to Beni-Suef University, taking on various important roles, including Assistant Professor in the Physical Therapy Department for Internal Medicine. From March 2012 to 2021, she also served as Vice Dean for Education and Student Affairs. Since 2021, she has been the Dean of the Faculty of Physical Therapy at Beni-Suef University, where she continues to contribute significantly to both the field of physical therapy and academic administration.

Activities:

Dr. Sherin Mehani has made significant contributions to the field of physical therapy through a range of roles and initiatives. From 2008 to 2012, she actively participated in Cairo University’s quality and accreditation plans as a faculty committee member and served as the secretary of the Graduate Studies and Research Committee. She was responsible for overseeing the laboratory for lung function and cardiopulmonary efficiency, supporting both academic research and clinical evaluations. Additionally, Dr. Mehani managed the pulmonary function testing and cardiopulmonary exercise testing lab at Cairo University.

Her commitment to education is evident through her creation of an e-learning course on cardiac rehabilitation for third-year students from 2009 to 2015 and her involvement in developing curricula for various courses, including exercise physiology and cardiopulmonary physical therapy. Dr. Mehani played a pivotal role in establishing student laboratories and outpatient clinics at Beni Suef University and organized the first student conference on modern electrical therapy techniques.

Dr. Mehani also supervised the Physical Therapy Studies Department at the National Institute for Science and Studies of the Elderly, preparing and overseeing numerous research plans. Her contributions extend to developing the research plan for the College of Physical Therapy and preparing postgraduate courses at Beni Suef University. She has taught various courses at both Cairo and Beni Suef Universities and supervised approximately fifty master’s and doctoral theses, covering topics such as aerobic training, cardiac rehabilitation, and the impact of various therapies on health outcomes. Her extensive involvement underscores her dedication to advancing physical therapy through research, teaching, and administration.

Top Notable Publications:

Mehani, S.H.M., Helmy, Z.M., Adel, W., & Mohamed, M.I. (2024). Revealing the role of high-intensity interval training combined with inspiratory muscle training on atrial fibrillation associated with chronic heart failure: Is there a shift towards anti-remodelling adaptation? European Journal of Preventive Cardiology, 31(11), 1420–1424. [DOI or URL if available]

Mohammed, M., Mehani, S., Aziz, A.A., Mohamed, M.F., & Nahas, N.E. (2023). Erratum: Efficacy of threshold inspiratory muscle trainer versus diaphragmatic plus pursed lip breathing in occupational COPD. Beni-Suef University Journal of Basic and Applied Sciences, 12(1), 92. [DOI or URL if available]

Mohammed, M., Hassan, S., Aziz, A.A., Mohamed, M.F., & El Nahas, N. (2023). Efficacy of threshold inspiratory muscle trainer versus diaphragmatic plus pursed lip breathing in occupational COPD. Beni-Suef University Journal of Basic and Applied Sciences, 12(1), 73. [DOI or URL if available]

Elhamrawy, M.Y., Mohamed, S., Bahnasy, W., Elkholy, A., & Said, M. (2021). Effect of vestibular rehabilitation therapy on spatio-temporal gait parameters in elderly patients with post-stroke hemineglect. Advances in Rehabilitation, 35(3), 17–24. [DOI or URL if available]

Helmy, Z.M., Mehani, S.H.M., El-Refaey, B.H., Al-Salam, E.H.A., & Felaya, E.-S.E.E.-S. (2019). Low-level laser therapy versus trunk stabilization exercises on sternotomy healing after coronary artery bypass grafting: A randomized clinical trial. Lasers in Medical Science, 34(6), 1115–1124. [DOI or URL if available]

Mehani, S.H.M. (2018). Novel molecular biomarkers’ response to a cardiac rehabilitation programme in patients with ischaemic heart diseases. European Journal of Physiotherapy, 20(4), 235–243. [DOI or URL if available]

Mehani, S.H.M. (2017). Comparative study of two different respiratory training protocols in elderly patients with chronic obstructive pulmonary disease. Clinical Interventions in Aging, 12, 1705–1715. [DOI or URL if available]

Mehani, S.H.M. (2017). Cardiopulmonary rehabilitation program impact on prognostic markers in selected patients with resting and exercise-induced ventilatory inefficiency: A clinical trial. Journal of Physical Therapy Science, 29(10), 1803–1810. [DOI or URL if available]

Mehani, S.H.M. (2017). Immunomodulatory effects of two different physical therapy modalities in patients with chronic obstructive pulmonary disease. Journal of Physical Therapy Science, 29(9), 1527–1533. [DOI or URL if available]

Mehani, S.H.M. (2013). Correlation between changes in diastolic dysfunction and health-related quality of life after cardiac rehabilitation program in dilated cardiomyopathy. Journal of Advanced Research, 4(2), 189–200. [DOI or URL if available]